Baidu
map

肿瘤科指南

订阅

MedSci主页 / 所有栏目 / 肿瘤科指南

2018 ESTRO指南：局部进展期非小细胞肺癌治疗中靶区定义

2018-03-28 欧洲放射肿瘤学学会 Radiother Oncol. 2018 Mar 28.

非小细胞肺癌放疗靶区

放射治疗在局部进展期非小细胞肺癌的根治中起了重要作用，欧洲放射肿瘤学学会(ESTRO)ACROP委员会针对放疗靶区勾画提出了指导建议，内容涉及局部进展期非小细胞肺癌的诊断和影像学检查，计划CT扫描，放疗接话附加影像检查，放疗剂量等。

中文标题：

2018 ESTRO指南：局部进展期非小细胞肺癌治疗中靶区定义

英文标题：

ESTRO ACROP guidelines for target volume definition in the treatment of locally advanced non-small cell lung cancer

发布机构：

欧洲放射肿瘤学学会

发布日期：

2018-03-28

简要介绍：

放射治疗在局部进展期非小细胞肺癌的根治中起了重要作用，欧洲放射肿瘤学学会(ESTRO)ACROP委员会针对放疗靶区勾画提出了指导建议，内容涉及局部进展期非小细胞肺癌的诊断和影像学检查，计划CT扫描，放疗接话附加影像检查，放疗剂量等。

 

拓展指南：与非小细胞肺癌相关指南：

相关资料下载：
[AttachmentFileName(sort=100, fileName=2018 ESTRO指南：局部进展期非小细胞肺癌治疗中靶区定义)] GetToolGuiderByIdResponse(projectId=1, id=d14321c0015e631d, title=2018 ESTRO指南：局部进展期非小细胞肺癌治疗中靶区定义, enTitle=ESTRO ACROP guidelines for target volume definition in the treatment of locally advanced non-small cell lung cancer, guiderFrom=Radiother Oncol. 2018 Mar 28., authorId=null, author=, summary=放射治疗在局部进展期非小细胞肺癌的根治中起了重要作用，欧洲放射肿瘤学学会(ESTRO)ACROP委员会针对放疗靶区勾画提出了指导建议，内容涉及局部进展期非小细胞肺癌的诊断和影像学检查，计划CT扫描，放疗接话附加影像检查，放疗剂量等。 , cover=, journalId=null, articlesId=null, associationId=1624, associationName=欧洲放射肿瘤学学会, associationIntro=, copyright=0, guiderPublishedTime=Wed Mar 28 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<P>放射治疗在局部进展期非小细胞肺癌的根治中起了重要作用，欧洲放射肿瘤学学会(ESTRO)ACROP委员会针对放疗靶区勾画提出了指导建议，内容涉及局部进展期非小细胞肺癌的诊断和影像学检查，计划CT扫描，放疗接话附加影像检查，放疗剂量等。 </P> <P> </P>拓展指南：<STRONG>与<FONT color=red>非小细胞肺癌</FONT>相关指南：</STRONG><BR> <UL> <LI><A title=NCCN临床实践指南：非小细胞肺癌（2018.V3） target=_blank href="//www.sandwebs.com/guideline/show_article.do?id=61b921c0015593c2">NCCN临床实践指南：非小细胞肺癌（2018.V3）</A> <LI><A title=NCCN临床实践指南：非小细胞肺癌（2018.V2） target=_blank href="//www.sandwebs.com/guideline/show_article.do?id=4c45f1c00153a02f">NCCN临床实践指南：非小细胞肺癌（2018.V2）</A> <LI><A title=NCCN临床实践指南：非小细胞肺癌（2018.V1） target=_blank href="//www.sandwebs.com/guideline/show_article.do?id=53b9d1c001525291">NCCN临床实践指南：非小细胞肺癌（2018.V1）</A> <LI><A title=NCCN临床实践指南：非小细胞肺癌（2017.V9） target=_blank href="//www.sandwebs.com/guideline/show_article.do?id=19d8b1c00150618e">NCCN临床实践指南：非小细胞肺癌（2017.V9）</A> <LI><A title=NCCN临床实践指南：非小细胞肺癌（2017.V8） target=_blank href="//www.sandwebs.com/guideline/show_article.do?id=d6bd81c001a9267c">NCCN临床实践指南：非小细胞肺癌（2017.V8）</A> 更多信息请点击：<A target=_blank href="//www.sandwebs.com/guideline/list.do?q=%E9%9D%9E%E5%B0%8F%E7%BB%86%E8%83%9E%E8%82%BA%E7%99%8C">有关非小细胞肺癌更多指南</A></LI></UL>, tagList=[TagDto(tagId=276, tagName=非小细胞肺癌), TagDto(tagId=804, tagName=放疗), TagDto(tagId=2397, tagName=靶区)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=40, categoryName=影像放射, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=2, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=8828, appHits=269, showAppHits=0, pcHits=6172, showPcHits=3711, likes=138, shares=10, comments=13, approvalStatus=1, publishedTime=Fri Apr 06 21:56:39 CST 2018, publishedTimeString=2018-03-28, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Fri Apr 06 21:56:39 CST 2018, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 13:49:23 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2018 ESTRO指南：局部进展期非小细胞肺癌治疗中靶区定义)])
2018 ESTRO指南：局部进展期非小细胞肺癌治疗中靶区定义
下载请点击：
评论区 (12)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2211071, encodeId=d4b522110e141, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33a98582049, createdName=ms1000000716084190, createdTime=Fri Jun 21 21:45:43 CST 2024, time=2024-06-21, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=906146, encodeId=dfb090614615, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3da31896401, createdName=ms3234097737105654, createdTime=Tue Dec 08 20:42:05 CST 2020, time=2020-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=906166, encodeId=a5c0906166f3, content=好东西，就是积分不够, beContent=null, objectType=guider, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3da31896401, createdName=ms3234097737105654, createdTime=Tue Dec 08 21:31:35 CST 2020, time=2020-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=356224, encodeId=f2de356224fa, content=一起学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc512268027, createdName=1219b02am66(暂无昵称), createdTime=Sun Dec 23 21:01:58 CST 2018, time=2018-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=350602, encodeId=d335350602e3, content=非常感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a0e02470789, createdName=124389cfm93暂无昵称, createdTime=Fri Oct 26 22:44:48 CST 2018, time=2018-10-26, status=1, ipAttribution=)]
    2024-06-21 ms1000000716084190 来自山东省

    非常好

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2211071, encodeId=d4b522110e141, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33a98582049, createdName=ms1000000716084190, createdTime=Fri Jun 21 21:45:43 CST 2024, time=2024-06-21, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=906146, encodeId=dfb090614615, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3da31896401, createdName=ms3234097737105654, createdTime=Tue Dec 08 20:42:05 CST 2020, time=2020-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=906166, encodeId=a5c0906166f3, content=好东西，就是积分不够, beContent=null, objectType=guider, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3da31896401, createdName=ms3234097737105654, createdTime=Tue Dec 08 21:31:35 CST 2020, time=2020-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=356224, encodeId=f2de356224fa, content=一起学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc512268027, createdName=1219b02am66(暂无昵称), createdTime=Sun Dec 23 21:01:58 CST 2018, time=2018-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=350602, encodeId=d335350602e3, content=非常感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a0e02470789, createdName=124389cfm93暂无昵称, createdTime=Fri Oct 26 22:44:48 CST 2018, time=2018-10-26, status=1, ipAttribution=)]
    2020-12-08 ms3234097737105654

    非常好

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2211071, encodeId=d4b522110e141, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33a98582049, createdName=ms1000000716084190, createdTime=Fri Jun 21 21:45:43 CST 2024, time=2024-06-21, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=906146, encodeId=dfb090614615, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3da31896401, createdName=ms3234097737105654, createdTime=Tue Dec 08 20:42:05 CST 2020, time=2020-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=906166, encodeId=a5c0906166f3, content=好东西，就是积分不够, beContent=null, objectType=guider, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3da31896401, createdName=ms3234097737105654, createdTime=Tue Dec 08 21:31:35 CST 2020, time=2020-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=356224, encodeId=f2de356224fa, content=一起学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc512268027, createdName=1219b02am66(暂无昵称), createdTime=Sun Dec 23 21:01:58 CST 2018, time=2018-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=350602, encodeId=d335350602e3, content=非常感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a0e02470789, createdName=124389cfm93暂无昵称, createdTime=Fri Oct 26 22:44:48 CST 2018, time=2018-10-26, status=1, ipAttribution=)]
    2020-12-08 ms3234097737105654

    好东西，就是积分不够

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2211071, encodeId=d4b522110e141, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33a98582049, createdName=ms1000000716084190, createdTime=Fri Jun 21 21:45:43 CST 2024, time=2024-06-21, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=906146, encodeId=dfb090614615, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3da31896401, createdName=ms3234097737105654, createdTime=Tue Dec 08 20:42:05 CST 2020, time=2020-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=906166, encodeId=a5c0906166f3, content=好东西，就是积分不够, beContent=null, objectType=guider, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3da31896401, createdName=ms3234097737105654, createdTime=Tue Dec 08 21:31:35 CST 2020, time=2020-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=356224, encodeId=f2de356224fa, content=一起学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc512268027, createdName=1219b02am66(暂无昵称), createdTime=Sun Dec 23 21:01:58 CST 2018, time=2018-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=350602, encodeId=d335350602e3, content=非常感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a0e02470789, createdName=124389cfm93暂无昵称, createdTime=Fri Oct 26 22:44:48 CST 2018, time=2018-10-26, status=1, ipAttribution=)]
    2018-12-23 1219b02am66(暂无昵称)

    一起学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2211071, encodeId=d4b522110e141, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33a98582049, createdName=ms1000000716084190, createdTime=Fri Jun 21 21:45:43 CST 2024, time=2024-06-21, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=906146, encodeId=dfb090614615, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3da31896401, createdName=ms3234097737105654, createdTime=Tue Dec 08 20:42:05 CST 2020, time=2020-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=906166, encodeId=a5c0906166f3, content=好东西，就是积分不够, beContent=null, objectType=guider, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3da31896401, createdName=ms3234097737105654, createdTime=Tue Dec 08 21:31:35 CST 2020, time=2020-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=356224, encodeId=f2de356224fa, content=一起学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc512268027, createdName=1219b02am66(暂无昵称), createdTime=Sun Dec 23 21:01:58 CST 2018, time=2018-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=350602, encodeId=d335350602e3, content=非常感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a0e02470789, createdName=124389cfm93暂无昵称, createdTime=Fri Oct 26 22:44:48 CST 2018, time=2018-10-26, status=1, ipAttribution=)]
    2018-10-26 124389cfm93暂无昵称

    非常感谢

    0

以上为热门评论，梅斯医学App还有更多内容

相关指南

2017 多机构治疗建议：复发淋巴结阳性非小细胞肺癌1期疾病立体定向放射治疗后再照射治疗

国外肿瘤科相关专家小组（统称） · 2017-04-19

2017 CCO指南：早期不能手术的非小细胞肺癌患者根治性放疗

加拿大安大略癌症治疗中心(CCO,Cancer Care Ontario) · 2017-02-27

Baidu
map
Baidu
map
Baidu
map